Application note: Analyte quarterly Vol 1

Posted: 29 June 2018 | | No comments yet

Your comprehensive guide to multiplex and single protein detection…

We’re here to guide you to choose the best protein detection platform for your needs

What’s better than a well-validated, sensitive, reproducible, robust immunoassay that fits your study requirements? Having a scientific partner offering you a variety of high performance assay platforms. Whether you need rich profiling data from a multiplex panel using Luminex® technology, ultrasensitive detection from an SMC™ assay, robust ELISAs, or maximum throughput from a Gyrolab® workstation, we help you get data you trust.

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada

This application note is restricted - login or subscribe free to access

Drug Target Review - Issue 2 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here


Related organisations